Si-Bone Inc (SIBN)

Feb 24, 2025, 10:29 PM EST - 12 days ago

SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 4:09 PM EST - 12 days ago

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

Feb 21, 2025, 8:00 AM EST - 16 days ago

Bruker Appoints Laura Francis to its Board of Directors

BRKR

Feb 3, 2025, 4:09 PM EST - 4 weeks ago

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Nov 20, 2024, 4:09 PM EST - 3 months ago

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

Nov 12, 2024, 10:42 PM EST - 4 months ago

SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:09 PM EST - 4 months ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Nov 5, 2024, 8:30 AM EST - 4 months ago

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Oct 22, 2024, 4:09 PM EDT - 4 months ago

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 10, 2024, 8:30 AM EDT - 5 months ago

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

Aug 22, 2024, 4:30 PM EDT - 7 months ago

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

Aug 20, 2024, 8:30 AM EDT - 7 months ago

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

Aug 6, 2024, 8:30 AM EDT - 7 months ago

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

Aug 5, 2024, 11:23 PM EDT - 7 months ago

SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:09 PM EDT - 7 months ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

Jul 15, 2024, 4:09 PM EDT - 8 months ago

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

Jun 5, 2024, 4:09 PM EDT - 9 months ago

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

May 7, 2024, 9:00 AM EDT - 10 months ago

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

May 6, 2024, 8:47 PM EDT - 10 months ago

SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript

May 6, 2024, 4:09 PM EDT - 10 months ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

Apr 29, 2024, 9:00 AM EDT - 11 months ago

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

Apr 15, 2024, 4:09 PM EDT - 11 months ago

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

Mar 4, 2024, 4:09 PM EST - 1 year ago

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

Feb 26, 2024, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

Feb 5, 2024, 4:09 PM EST - 1 year ago

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

Jan 30, 2024, 8:30 AM EST - 1 year ago

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

Jan 8, 2024, 8:30 AM EST - 1 year ago

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

Nov 16, 2023, 12:47 PM EST - 1 year ago

Sizing Up SI-BONE After Q3 Earnings

Nov 14, 2023, 4:09 PM EST - 1 year ago

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

Nov 6, 2023, 9:22 PM EST - 1 year ago

SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

Nov 1, 2023, 4:09 PM EDT - 1 year ago

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

Oct 16, 2023, 4:09 PM EDT - 1 year ago

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023

Sep 5, 2023, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods

Aug 31, 2023, 4:28 PM EDT - 1 year ago

SI-BONE: Another Record Quarter, Reinvesting For Future Growth, Reiterate Buy

Aug 29, 2023, 4:09 PM EDT - 1 year ago

SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023

Aug 7, 2023, 9:40 PM EDT - 1 year ago

SI-BONE, Inc. (SIBN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance

Jul 19, 2023, 4:09 PM EDT - 1 year ago

SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023

Jul 15, 2023, 5:07 AM EDT - 1 year ago

SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023

Jun 15, 2023, 12:14 PM EDT - 1 year ago

SI-BONE: Rating Higher On Fundamental, Economic Grounds

May 24, 2023, 4:09 PM EDT - 1 year ago

SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023

May 4, 2023, 10:29 PM EDT - 2 years ago

SI-BONE Announces Pricing of Public Offering of Common Stock

May 4, 2023, 4:09 PM EDT - 2 years ago

SI-BONE Announces Launch of Public Offering of Common Stock

May 1, 2023, 10:20 PM EDT - 2 years ago

SI-BONE, Inc. (SIBN) Q1 2023 Earnings Call Transcript

May 1, 2023, 4:09 PM EDT - 2 years ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance

Apr 24, 2023, 4:09 PM EDT - 2 years ago

SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference

Apr 10, 2023, 4:09 PM EDT - 2 years ago

SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023

Feb 27, 2023, 9:02 PM EST - 2 years ago

SI-BONE, Inc. (SIBN) Q4 2022 Earnings Call Transcript

Feb 27, 2023, 4:09 PM EST - 2 years ago

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance